Sistemnyy podkhod k obespecheniyu kachestva gemopoeticheskikh stvolovykh kletok pupovinnoy krovi dlya klinicheskogo primeneniya

I V Kobzeva; T A Astrelina; M V Yakovleva; E A Podkolzina; E E Karpova; L L Lebedeva; E V Boyakova; Ya A Kruglova; N K Shakhpazyan; E V Skorobogatova; O V Paina

doi:10.23868/gc121540

Genes & Cells ›› 2011, Vol. 6 ›› Issue (1) : 55 -58. DOI: 10.23868/gc121540

Articles

other

Sistemnyy podkhod k obespecheniyu kachestva gemopoeticheskikh stvolovykh kletok pupovinnoy krovi dlya klinicheskogo primeneniya

Author information +

History +

PDF

Cite this article

Download citation ▾

I V Kobzeva, T A Astrelina, M V Yakovleva, E A Podkolzina, E E Karpova, L L Lebedeva, E V Boyakova, Ya A Kruglova, N K Shakhpazyan, E V Skorobogatova, O V Paina. Sistemnyy podkhod k obespecheniyu kachestva gemopoeticheskikh stvolovykh kletok pupovinnoy krovi dlya klinicheskogo primeneniya. Genes & Cells, 2011, 6(1): 55-58 DOI:10.23868/gc121540

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Artitage J.O. Bone marrow transplantation. N. Engl. J. Med. 1994; 330: 827-38.

[2]	Thomas E.D., Lochte H.L.. Jr, Lu W.C., Ferrebee J.W. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N. Engl. J. Med. 1957; 257(11): 491-6.

[3]	Talbot T.R., Elson L.A. Protection of August Rats against Lethal Doses of a Dirre. Homologue of Myeleran by Isologous Bone Marrow. Nature 1958; 181: 684.

[4]	Coplan E.A., Hematopoietic stem cell transplantation. N. Engl. J. Med. 2006; 354: 1813-26.

[5]	Howe C.W., Radde-Stepaniak T. Hematopoietic cell donor registries. In Thomas E., Blume K.G., Forman S.J., eds. Hematopoietic Cell transplantation, 2nd. Malden, MA Blackwell Science 1999; 503-14.

[6]	Oudshoom M., Foeken L., Wiegand T. Editors. Stem cell donor registries annual report 2007, 11th edition. WMDA: Netherlands, 2008.

[7]	Falkenburg J.H.F., Lim F.T.H. Использование пуповинной крови вместо костного мозга для аллогенной трансплантации гемопоэтических стволовых клеток. РМЖ 1996; 3 (4): 24-31.

[8]	Абдулкадыров К.М., Романенко Н.А., Старков Н.Н. Получение и клиническое применение периферических гемопоэтических стволовых клеток из пуповинной крови. Вопросы онкологии 2000; 46(5): 513-20.

[9]	Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp. Hematol. 2000; 28(11): 1197-205.

[10]	Kollman C., Abella E., Baitty R. Assessment of optimal size and composition of US National Registry of Hematopoietic Stem Cell Donors. Transplant. 2004; 78: 89-95.

[11]	Rubinstein P. Why cord blood? Hum. Immunol. 2006; 67: 398-404.

[12]	Forte K.J. Alternative donor sourses in pediatric bone marrow transplantation. J. Pediatr. Oncol. Nurs. 1997; 14(4); 213-24.

[13]	Broxmeyer H.E., Douglas G.W., Hangoc G. et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. PNAS USA 1989; 86(10): 3828-32.

[14]	Gluckman E., Broxmeyer H.A., Auerbach A.D., Friedman H.S., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 1989; 321(17): 1174-8.

[15]	Szabolcs P., Park K.D., Reese M. et al. Coexistent naive phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood. Exp. Hematol. 2003; 31: 708-14.

[16]	Gluckman E., Rocha V., Boyer-Chammard A. et al. Outcome of cord-blood transplantation from related and unrelated donors: Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N. Engl. J. Med. 1997; 337: 373-81.

[17]	Wagner J.E., Barker J.N., DeFor T.E. et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611-8.

[18]	Kernan N.A., Bartsch G., Ash R.C. et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N. Engl. J. Med. 1993; 328: 593-602.

[19]	Hongeng S., Krance R.A., Bowman L.C. et al. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet 1997; 350: 767-71.